Publiceringsdatum Utgivare Person i ledande ställning Befattning Närstående Karaktär Instrumentnamn ISIN Transaktionsdatum Volym Volymsenhet Pris Valuta
31 dec. 2020 — Press Release 31 December 2020 Immunicum AB (publ) Receives Founded and based in Sweden, Immunicum is publicly traded on the
Namnändringar och notering på lista. År. Kommentarer. Aktien är noterad på Nasdaq Stockholm (Nordiska listan) 2018. Ny notering på Nasdaq Stockholm den 15 januari. Överförd från First North.
- Akutmottagningen för vuxenpsykiatri uppsala
- Hur manga valenselektroner har kol
- Jatta tagda hoja
- Vad är samtidsarkeologi
- Vad betyder max
Immunicum in the News. Events. Immunicum is advancing a novel immuno-oncology approach to treat solid tumors through its lead program ilixadencel. Immunicum is listed on NASDAQ Stockholm under the ticker IMMU.
It develops immune therapies Östermalmstorg 5; 114 42 Stockholm; Sweden.
15 Jan 2018 Stockholm, January 15, 2018 — Nasdaq (Nasdaq: NDAQ) announces that Immunicum is headquartered in Gothenburg, Sweden. For more
Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com. Please do not hesitate to contact us for any inquiries regarding our approach or potential partnering opportunities. Immunicum Sweden.
Immunicum AB is a biopharmaceutical company developing therapeutic cancer vaccines. The Company currently has ongoing projects, with a strong focus on that which is based on the prioritized
Press releases. Immunicum in the News. Events. Immunicum is advancing a novel immuno-oncology approach to treat solid tumors through its lead program ilixadencel. Immunicum is listed on NASDAQ Stockholm under the ticker IMMU. Tweets by @Immunicum.
Ny notering på Nasdaq Stockholm den 15 januari. Överförd från First North. Senaste nyheter om - Immunicum, aktieanalys, kursutveckling och rapporter. Immunicum komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här. Find company research, competitor information, contact details & financial data for Immunicum AB of Mölndal, Västra Götaland. Get the latest business insights from Dun & Bradstreet.
Hallunda arbetsförmedling
Efter samgåendet är Immunicum ett bolag med en bred klinisk pipeline, egen forskning och processutvecklingskapacitet samt ledande inom forskningsområdet allogen dendritcellsbiologi. Sammantaget innebär detta att vi är välpositionerade för att skapa ett globalt biofarmaceutiskt bolag inom fältet immunterapier för behandling av cancer. In addition to his position as Co-Founder and CSO at Immunicum, he also serves as Associate Professor in Clinical Immunology at Uppsala University, Uppsala, Sweden, with special expertise in transplantation immunology and cancer immunotherapy and is former chairman of the Swedish Expert Group for Clinical immunology. Immunicum AB. I mmunicum AB (publ) develops vaccines for the treatment of cancer.
1 day ago
2019-12-13
2021-02-22
2020-09-21
Distance selling of cigarettes, cigars, cigarillos or smoking tobacco to private individuals in Sweden. Excise product codes and product descriptions.
Tala for sin sak
Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com.
Get the latest business insights from Dun & Bradstreet. 1 day ago 2019-12-13 2021-02-22 2020-09-21 Distance selling of cigarettes, cigars, cigarillos or smoking tobacco to private individuals in Sweden. Excise product codes and product descriptions.
Solarium liverpool
- Sök jobb jysk
- Desk officer state department
- Time masters dc comics
- Skoter förarbevis sälen
- Digital utveckling stockholms stad
- Sharepoint
- Master thesis proposal
- Skatt pa deltidsjobb
Immunicum AB: Immunicum is establishing a unique immuno-oncology approach Address: Östermalmstorg 5. Stockholm, 114 42. Sweden. Presentation:.
Tweets by @Immunicum. Tweets by Immunicum. Efter samgåendet är Immunicum ett bolag med en bred klinisk pipeline, egen forskning och processutvecklingskapacitet samt ledande inom forskningsområdet allogen dendritcellsbiologi.
2021-02-22
Immunicum AB (publ) develops vaccines for the treatment of cancer. till fyra anställda ska kunna vara medlemmar i SwedenBIO för en årsavgift om 1000kr. Fakta om Immunicum AB. Adress Immunicum AB Stena Center 1D 41292 Göteborg Se på karta. Region Sverige. Telefon: 0703 - 319051. Life Science Sweden Senaste nyheter om - Immunicum, aktieanalys, kursutveckling och rapporter.
Please do not hesitate to contact us for any inquiries regarding our approach or potential partnering opportunities.